Discontinued — last reported Q4 '25
T Rowe Price Group Share Buybacks increased by 139.8% to $333.50M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 55.0%, from $215.20M to $333.50M. Over 4 years (FY 2021 to FY 2025), Share Buybacks shows a downward trend with a -14.1% CAGR.
High repurchases often signal management's confidence in the company's valuation or a strategy to improve earnings per share.
The cash outflow associated with the company buying back its own shares from the open market. This is a primary method f...
Common among mature, cash-generative companies; peers in the healthcare sector often balance this with R&D investment.
share_repurchases| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $52.20M | $181.70M | $645.40M | $320.10M | $190.30M | $217.50M | $121.90M | $8.20M | $42.20M | $90.80M | $113.20M | $83.10M | $112.40M | $73.60M | $68.10M | $215.20M | $113.10M | $153.50M | $139.10M | $333.50M |
| QoQ Change | — | +248.1% | +255.2% | -50.4% | -40.5% | +14.3% | -44.0% | -93.3% | +414.6% | +115.2% | +24.7% | -26.6% | +35.3% | -34.5% | -7.5% | +216.0% | -47.4% | +35.7% | -9.4% | +139.8% |
| YoY Change | — | — | — | — | +264.6% | +19.7% | -81.1% | -97.4% | -77.8% | -58.3% | -7.1% | +913.4% | +166.4% | -18.9% | -39.8% | +159.0% | +0.6% | +108.6% | +104.3% | +55.0% |